Jackson Acquisition Co II Files Q3 2024 10-Q

TL;DR

Jackson Acquisition Co II filed its 10-Q for Q3 2024. Blank check company in real estate.

AI Summary

Jackson Acquisition Co II filed its 10-Q for the quarter ended September 30, 2024. The company, incorporated in the Cayman Islands, is a blank check company operating in the Real Estate & Construction sector. Its principal executive offices are located at 2655 Northwinds Parkway, Alpharetta, GA.

Why It Matters

This filing provides investors with an update on the financial performance and operational status of Jackson Acquisition Co II for the third quarter of 2024.

Risk Assessment

Risk Level: low — This is a routine quarterly filing for a blank check company, providing standard financial and operational updates.

Key Players & Entities

• Jackson Acquisition Co II (company) — Registrant
• September 30, 2024 (date) — Quarter end date
• 2655 Northwinds Parkway, Alpharetta, GA 30009 (location) — Principal executive offices
• Cayman Islands (location) — Jurisdiction of incorporation

FAQ

Key Financial Figures

• $0.0001 — LLC Class A ordinary share, par value $0.0001 per share JACS New York Stock Exchange

Filing Documents

• ea0226769-10q_jackson2.htm (10-Q) — 258KB
• ea022676901ex31-1_jackson2.htm (EX-31.1) — 12KB
• ea022676901ex31-2_jackson2.htm (EX-31.2) — 12KB
• ea022676901ex32-1_jackson2.htm (EX-32.1) — 5KB
• ea022676901ex32-2_jackson2.htm (EX-32.2) — 5KB
• 0001213900-25-003881.txt ( ) — 2315KB
• jacs-20240930.xsd (EX-101.SCH) — 26KB
• jacs-20240930_cal.xml (EX-101.CAL) — 10KB
• jacs-20240930_def.xml (EX-101.DEF) — 141KB
• jacs-20240930_lab.xml (EX-101.LAB) — 197KB
• jacs-20240930_pre.xml (EX-101.PRE) — 135KB
• ea0226769-10q_jackson2_htm.xml (XML) — 147KB

Financial Information

Part I. Financial Information

Financial Statements

Item 1. Financial Statements 1 Condensed Balance Sheet as of September 30, 2024 (Unaudited) 1 Condensed Statement of Operations For the Period from September 11, 2024 (Inception) Through September 30, 2024 (Unaudited) 2 Condensed Statement of Changes in Shareholders' Deficit For the Period from September 11, 2024 (Inception) Through September 30, 2024 (Unaudited) 3 Condensed Statement of Cash Flows For the Period from September 11, 2024 (Inception) Through September 30, 2024 (Unaudited) 4 Notes to Condensed Financial Statements (Unaudited) 5

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 15

Quantitative and Qualitative Disclosures Regarding Market Risk

Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk 17

Controls and Procedures

Item 4. Controls and Procedures 17

Other Information

Part II. Other Information

Legal Proceedings

Item 1. Legal Proceedings 18

Risk Factors

Item 1A. Risk Factors 18

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 18

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 18

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 18

Other Information

Item 5. Other Information 18

Exhibits

Item 6. Exhibits 18

Signatures

Part III. Signatures 19 i

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements. JACKSON ACQUISITION COMPANY II CONDENSED BALANCE SHEET SEPTEMBER 30, 2024 Assets Current assets Prepaid expenses $ 3,249 Total current assets 3,249 Deferred offering costs 190,551 Total Assets $ 193,800 Liabilities and Shareholders' Deficit Current Liabilities Accrued offering costs $ 93,000 Accounts payable and accrued expenses 5,000 Promissory note - related party 120,368 Total Liabilities 218,368 Commitments and Contingencies (Note 6) Shareholders' Deficit Preference shares, $ 0.0001 par value; 1,000,000 shares authorized; none issued or outstanding — Class A ordinary shares, $ 0.0001 par value; 200,000,000 shares authorized; none issued or outstanding — Class B ordinary shares, $ 0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding (1) 575 Additional paid-in capital 24,425 Accumulated deficit ( 49,568 ) Total Shareholders' Deficit ( 24,568 ) Total Liabilities and Shareholders' Deficit $ 193,800 (1) Includes an aggregate of up to 750,000 Class B ordinary shares subject to forfeiture by the holders thereof depending on the extent to which the underwriter's over-allotment option is exercised (see Note 5). On December 11, 2024, the Company consummated its IPO and sold 23,000,000 Units, including 3,000,000 Units sold pursuant to the full exercise of the underwriters' option to purchase additional units to cover the over-allotment, hence the 750,000 shares of Class B ordinary shares were no longer subject to forfeiture. The accompanying notes are an integral part of the unaudited condensed financial statements. 1 JACKSON ACQUISITION COMPANY II CONDENSED STATEMENT OF OPERATIONS FOR THE PERIOD FROM SEPTEMBER 11, 2024 (INCEPTION) THROUGH SEPTEMBER 30, 2024 (UNAUDITED) General and administrative costs $ 49,568 Loss from operations ( 49,568 ) Net loss $ ( 49,568 ) Weighted average shares outstanding, Class B ordinary shares (1

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS SEPTEMBER 30, 2024 (UNAUDITED) NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Jackson Acquisition Company II (the "Company") is a blank check company incorporated as a Cayman Islands exempted company on September 11, 2024. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses ("Business Combination"). While the Company may pursue an initial business combination target in any industry or geographic location, the Company intends to focus its search for a target business by concentrating its efforts in identifying high-quality businesses with a focus on healthcare services, healthcare technology, or otherwise focused on the healthcare industry. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2024, the Company had not commenced any operations. All activity for the period from September 11, 2024 (inception) through September 30, 2024, relates to the Company's formation and the initial public offering ("Initial Public Offering"), which is described below. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The registration statement for the Company's Initial Public Offering was declared effective on December 9, 2024. On December 11, 2024, the Company consummated the Initial Public Offering of 23,000,000 units (the "Units" and, with respect to the shares of Class A ordinary shares included in the Units being offered, the "Public Shares"), which includes the full exercise by the underw

View Full Filing

View this 10-Q filing on SEC EDGAR